Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways
Bibliographic Data
Apoptosis · Biology · Blot · Cancer · Hepatocellular carcinoma · In vivo · Liver cancer · Metastasis · Pathology · Cancer, Lipids, and Metabolism · Inflammatory mediators and NSAID effects · Medicine · TGF-β signaling in diseases · Biochemistry · Cancer Research · Internal Medicine · Pharmacology
Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription
Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation
Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation
Compound Astragalus and Salvia miltiorrhiza extracts modulate Mapk-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,67 |
| Citation span | 2023 - 2026 (4) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |